Horizons Weight Loss

Horizons Weight Loss in Dayton, Ohio, operates under the medical direction of Andre Harris, MD, focusing exclusively on physician-supervised weight management through pharmaceutical interventions and metabolic optimization. The clinic structures its programs around evidence-based pharmacotherapy, combining prescription appetite suppressants with newer peptide-based treatments to address the complex hormonal and metabolic factors that contribute to weight gain and plateau. Dr. Harris and his clinical team conduct comprehensive metabolic assessments before initiating treatment, evaluating thyroid function, insulin sensitivity, and hormonal balance to identify underlying barriers to weight loss that diet and exercise alone cannot overcome.

The clinic's peptide therapy offerings include Semaglutide and Tirzepatide, both GLP-1 receptor agonists that regulate blood sugar and reduce appetite through mechanisms that mimic naturally occurring incretin hormones. Semaglutide protocols at Horizons Weight Loss typically begin with low-dose subcutaneous injections, gradually titrating upward based on individual tolerance and response, while Tirzepatide programs leverage the medication's dual GIP and GLP-1 receptor activity for patients who require more aggressive metabolic intervention. Beyond GLP-1 therapies, the clinic incorporates Kisspeptin-10, a peptide that influences reproductive hormone pathways and has shown promise in addressing weight gain related to hormonal imbalances, particularly in patients experiencing metabolic changes during perimenopause or andropause. Traditional pharmacotherapy options, including phentermine (Adipex) and HCG protocols, remain available for patients whose medical history or treatment goals align better with these established interventions.

Dr. Harris brings a clinical approach that emphasizes individualized dosing and ongoing medication management rather than one-size-fits-all protocols. Each patient undergoes initial laboratory work to establish baseline metabolic markers, followed by regular follow-up appointments to monitor progress, adjust medication dosages, and address side effects or concerns as they arise. The medical team at Horizons Weight Loss maintains an active role throughout treatment, providing guidance on nutrition strategies that complement pharmaceutical interventions and helping patients navigate the physiological changes that occur during significant weight loss. Hormone replacement therapy services integrate with weight loss programs for patients whose metabolic challenges stem from testosterone deficiency, estrogen imbalance, or thyroid dysfunction, addressing the interconnected nature of hormonal health and body composition.

Patients visiting the Dayton clinic can expect in-person consultations that include body composition analysis, review of medical history and current medications, and discussion of realistic weight loss timelines based on their chosen treatment protocol. The clinic schedules follow-up visits at intervals appropriate to each medication—weekly for HCG protocols, monthly for GLP-1 therapies—ensuring that Dr. Harris or his clinical staff can monitor cardiovascular health, assess for potential side effects like nausea or gastrointestinal changes, and provide accountability throughout the treatment course. The practice does not offer telehealth services, requiring all patients to attend appointments at the Dayton location for medication dispensing, injection training, and progress monitoring.

Horizons Weight Loss distinguishes itself in the Dayton medical community through its exclusive focus on medically supervised weight loss rather than attempting to serve as a general wellness clinic. This specialization allows the clinical team to maintain deep expertise in the nuances of appetite-regulating medications, peptide therapy protocols, and the management of weight loss in patients with complicating factors like diabetes, hypertension, or polycystic ovary syndrome. The clinic's approach acknowledges that sustainable weight loss often requires pharmaceutical support to overcome biological set points and hormonal resistance, providing patients with medical tools that extend beyond lifestyle modification alone while maintaining the physician oversight necessary to use these interventions safely and effectively.